Conexeu Sciences Inc. (CNXU) Investor Relations Documents

Conexeu Sciences Inc. (CNXU) investor relations documents from the company's IR site: 10 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site

Published	Type	Document
2026-08-11	Press release	Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extrac
2026-07-07	Press release	A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill
2026-06-25	Press release	Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
2026-06-15	Press release	Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
2026-06-08	Press release	Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
2026-06-03	Press release	Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026 Read Press Release
2026-05-21	Press release	Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
2026-05-19	Press release	Conexeu Sciences Advances 3D Biofabricated Matrix to Move Breast Reconstruction Beyond Implants
	Press release	Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine Read Press Release
	Press release	UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine Read Press Release

CNXU overview · CNXU earnings · CNXU financials · CNXU KPIs · CNXU ownership · CNXU peers · CNXU filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.